Masato Ishigami
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Epidemiology top 1%
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
- Surgery 28
- Lipoproteins and Cardiovascular Health 19
- Cholesterol and Lipid Metabolism 13
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 18
- Co-authors
- Shizuya Yamashita (39 shared papers)Yūji Matsuzawa (27 shared papers)Naohiko Sakai (26 shared papers)Ken‐ichi Hirano (27 shared papers)Makoto Nishida (21 shared papers)Shinji Kihara (9 shared papers)Akifumi Matsuyama (15 shared papers)Tohru Funahashi (7 shared papers)
- Journals
- Journal of Atherosclerosis and Thrombosis (12 papers)Atherosclerosis (9 papers)European Journal of Clinical Investigation (5 papers)Atherosclerosis Supplements (4 papers)Biochemical and Biophysical Research Communications (4 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Masato Ishigami
69 papers receiving 4.2k citations
Masato Ishigami's Hit Papers
Peers
Comparison fields: 5 of 103
- Endocrinology, Diabetes and Metabolism 933
- Epidemiology 1.3k
- Cancer Research 486
- Cardiology and Cardiovascular Medicine 696
- Surgery 1.4k
Countries citing papers authored by Masato Ishigami
This map shows the geographic impact of Masato Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Ishigami more than expected).
Fields of papers citing papers by Masato Ishigami
This network shows the impact of papers produced by Masato Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Ishigami. The network helps show where Masato Ishigami may publish in the future.
Co-authors
The 25 scholars most cited alongside Masato Ishigami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages Hit paper breakdown → | 2001 | 1100 |
| 2 | 1995 | 284 | |
| 3 | 1997 | 231 | |
| 4 | 2005 | 192 | |
| 5 | 1995 | 145 | |
| 6 | 2007 | 129 | |
| 7 | 1998 | 129 | |
| 8 | 2006 | 120 | |
| 9 | 2003 | 119 | |
| 10 | 2008 | 110 | |
| 11 | 1998 | 105 | |
| 12 | 2008 | 92 | |
| 13 | 2002 | 80 | |
| 14 | 2007 | 80 | |
| 15 | 2009 | 77 | |
| 16 | 1998 | 75 | |
| 17 | 2000 | 70 | |
| 18 | 2002 | 60 | |
| 19 | 1997 | 59 | |
| 20 | 1999 | 51 |
About Masato Ishigami
Masato Ishigami is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 71 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Peroxisome Proliferator-Activated Receptors (14 papers), Cholesterol and Lipid Metabolism (13 papers), Cancer, Lipids, and Metabolism (9 papers), Lipid metabolism and disorders (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (933 citations), Epidemiology (1.3k citations), Cancer Research (486 citations), Cardiology and Cardiovascular Medicine (696 citations) and Surgery (1.4k citations). Masato Ishigami has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Shizuya Yamashita, Yūji Matsuzawa, Naohiko Sakai, Ken‐ichi Hirano, Makoto Nishida, Shinji Kihara, Akifumi Matsuyama, Tohru Funahashi, Kaoru Kameda-Takemura and Hiroshi Kuriyama. Their work appears in journals such as Journal of Atherosclerosis and Thrombosis, Atherosclerosis, European Journal of Clinical Investigation, Atherosclerosis Supplements and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.